-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk received positive feedback from CHMP for treating idiopathic short stature in children with the once-a-week medication Sogroya® in Europe.

Zhitongcaijing·09/18/2026 10:41:10
Listen to the news
Novo Nordisk received positive feedback from CHMP for treating idiopathic short stature in children with the once-a-week medication Sogroya® in Europe.